SOURCE: Mass Hysteria Entertainment

April 05, 2011 06:30 ET

Mass Hysteria Entertainment Company, Inc. Adds Dr. Murray Rosenthal to the Advisory Board

HOLLYWOOD, CA--(Marketwire - April 5, 2011) - Mass Hysteria Entertainment Company, Inc. (OTCBB: MHYS) is pleased to announce that Dr. Murray Rosenthal had made an investment in the company and has been appointed to the advisory board of Mass Hysteria Entertainment Company, Inc. Dr. Rosenthal joins two-time Academy Award-winning producer Albert S. Ruddy ("The Godfather" and "Million Dollar Baby"), award-winning director, John Landis, ("Animal House," "The Blues Brothers," Michael Jackson's landmark music video, "Thriller") and Oren Aviv, Twentieth Century Fox, Chief Marketing Executive.

"Mass Hysteria interested Dr. Rosenthal as an opportunity to explore ways in which audiences can be motivated to actively participate in a total media experience," said Mass Hysteria Entertainment CEO Daniel Grodnik. "He brings to his board role a diverse mixture of backgrounds in business and human behavior that we expect will add value to our company. Dr. Rosenthal will spearhead a team knowledgeable in experiential neuroscience that will have the ability to test and quantify audience reactions and interactions with our movies. This, we believe, will enhance our ability to deliver a truly unique media experience.

"There's no question in my mind that Mass Hysteria is doing something revolutionary in the film business," said Dr. Rosenthal. "My expertise in building successful management teams and growing businesses is something I'm excited to bring to Mass Hysteria."

About Mass Hysteria Entertainment Company, Inc.

Mass Hysteria Entertainment, Inc. is a new multi-media entertainment company created to produce film comedies for the young adult market with an interactive component. "Mass Hysteria is the next step in the evolution of the theatrical experience: a hybrid entertainment that combines movies with hand-held devices and the internet. Today's young moviegoer is ready for something radical at the multi-plex and we believe Mass Hysteria can change the filmic landscape," said CEO Daniel Grodnik. The company website is www.masshysteriafilms.com. For more information or media inquiries, please contact Nava at info@masshysteriafilms.com, +1 (323) 956-8388.

About Dr. Rosenthal

Dr. Murray Rosenthal is a board-certified psychiatrist and Fellow of the American Psychiatric Association. Dr Rosenthal has been instrumental in developing a successful clinical trials company and a toxicology laboratory.

Dr. Rosenthal was previously Chief Executive Officer of California Clinical Trials as well as the Senior Medical Officer and investor in Millennium Laboratories.

Dr. Rosenthal has a long history with the media. In the late 1980s he co-hosted a local talk radio show on KSDO in San Diego. For over 20 years he was a regular on local morning and news shows in San Diego as an often sough expert on topical issues. In 1995, he co-hosted the Sally Jesse Raphael Show from New York.

Forward-Looking Safe Harbor Statement

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future. There are a number of factors that could cause actual results and developments to differ materially from forecasted results. These risks and uncertainties include product demand, market competition, fluctuations in advertising payout, delays in website & application development, technical issues beyond our control, reliance on the various platforms that we build applications on, and risks inherent in our operations. For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov. All traffic statistics are recent averages.

Contact Information